A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Intervention: Drug: Cannabidiol Oral Solution [Epidiolex] Sponsor: Jazz Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials